Illumina Future Growth

Future criteria checks 3/6

Illumina is forecast to grow earnings and revenue by 70.4% and 4.8% per annum respectively. EPS is expected to grow by 74.9% per annum. Return on equity is forecast to be 19.9% in 3 years.

Key information

70.4%

Earnings growth rate

74.9%

EPS growth rate

Life Sciences earnings growth18.4%
Revenue growth rate4.8%
Future return on equity19.9%
Analyst coverage

Good

Last updated20 Nov 2024

Recent future growth updates

Recent updates

Illumina: Q3 Confirms Improving Fundamentals

Nov 05

We Think Illumina (NASDAQ:ILMN) Can Stay On Top Of Its Debt

Oct 21
We Think Illumina (NASDAQ:ILMN) Can Stay On Top Of Its Debt

Illumina Sees The Light: GRAIL Is Gone, Focus Restored (Rating Upgrade)

Aug 21

Illumina: Strengthening Competitive Position, Relevance And A Very Compelling Valuation

Jul 23

Illumina, Inc.'s (NASDAQ:ILMN) Share Price Could Signal Some Risk

Jul 01
Illumina, Inc.'s (NASDAQ:ILMN) Share Price Could Signal Some Risk

Illumina: Marriage Made In Hell Is (Finally) Over - Assessing Impact Of GRAIL Spin-Out

Jun 28

Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$106?

May 26
Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$106?

Illumina: Expect A Slow Rebound

May 07

Calculating The Fair Value Of Illumina, Inc. (NASDAQ:ILMN)

Apr 26
Calculating The Fair Value Of Illumina, Inc. (NASDAQ:ILMN)

Revenues Not Telling The Story For Illumina, Inc. (NASDAQ:ILMN)

Mar 20
Revenues Not Telling The Story For Illumina, Inc. (NASDAQ:ILMN)

Illumina: Stagnant Revenues And Shrinking Margins Amidst Rising Competition

Feb 23

Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?

Jan 26
Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?

Illumina: Volatility Galore, But Not Much Prospect Of Progress In 2024

Jan 19

Investors Appear Satisfied With Illumina, Inc.'s (NASDAQ:ILMN) Prospects As Shares Rocket 40%

Dec 21
Investors Appear Satisfied With Illumina, Inc.'s (NASDAQ:ILMN) Prospects As Shares Rocket 40%

Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued?

Dec 03
Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued?

Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?

Oct 24
Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?

Is There An Opportunity With Illumina, Inc.'s (NASDAQ:ILMN) 40% Undervaluation?

Oct 03
Is There An Opportunity With Illumina, Inc.'s (NASDAQ:ILMN) 40% Undervaluation?

At US$167, Is Illumina, Inc. (NASDAQ:ILMN) Worth Looking At Closely?

Aug 22
At US$167, Is Illumina, Inc. (NASDAQ:ILMN) Worth Looking At Closely?

The Big Trends: New Frontiers in Healthcare

Jul 13
The Big Trends: New Frontiers in Healthcare

Estimating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)

Jul 03
Estimating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)

Illumina (NASDAQ:ILMN) Is Carrying A Fair Bit Of Debt

Jun 13
Illumina (NASDAQ:ILMN) Is Carrying A Fair Bit Of Debt

Is It Time To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?

Apr 12
Is It Time To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?

Is Illumina (NASDAQ:ILMN) Using Too Much Debt?

Mar 14
Is Illumina (NASDAQ:ILMN) Using Too Much Debt?

Earnings and Revenue Growth Forecasts

NasdaqGS:ILMN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,7906641,3011,43818
12/31/20254,5005151,5031,40324
12/31/20244,321-1,13196293024
9/29/20244,390-1,585466697N/A
6/30/20244,429-3,044357520N/A
3/31/20244,493-1,290366545N/A
12/31/20234,504-1,161282478N/A
10/1/20234,465-1,125168401N/A
7/2/20234,461-4,186-224210N/A
4/2/20234,448-4,487-228230N/A
1/1/20234,584-4,404-74392N/A
10/2/20224,700-4,15379527N/A
7/3/20224,693-2053307N/A
4/3/20224,656701208435N/A
1/2/20224,526762337545N/A
10/3/20214,280907469669N/A
7/4/20213,9667698981,094N/A
4/4/20213,4736308901,081N/A
1/3/20213,2396568911,080N/A
9/27/20203,2386389331,117N/A
6/28/20203,3516931,0461,231N/A
3/29/20203,5569429411,134N/A
12/29/20193,5431,0028421,051N/A
9/29/20193,458973691908N/A
6/30/20193,405938701933N/A
3/31/20193,3978518231,085N/A
12/30/20183,3338268461,142N/A
9/30/20183,2436848291,136N/A
7/1/20183,103648N/A1,079N/A
4/1/20182,936567N/A962N/A
12/31/20172,752725N/A875N/A
10/1/20172,594775N/A843N/A
7/2/20172,487741N/A784N/A
4/2/20172,424730N/A848N/A
1/1/20172,398454N/A779N/A
10/2/20162,371440N/A757N/A
7/3/20162,314430N/A762N/A
4/3/20162,253415N/A692N/A
1/3/20162,220462N/A786N/A
9/27/20152,141510N/A560N/A
6/28/20152,071486N/A524N/A
3/29/20151,979430N/A531N/A
12/28/20141,861353N/A501N/A
9/28/20141,736281N/A488N/A
6/29/20141,612219N/A425N/A
3/30/20141,511208N/A336N/A
12/29/20131,421125N/A386N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ILMN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: ILMN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ILMN is expected to become profitable in the next 3 years.

Revenue vs Market: ILMN's revenue (4.8% per year) is forecast to grow slower than the US market (9% per year).

High Growth Revenue: ILMN's revenue (4.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ILMN's Return on Equity is forecast to be low in 3 years time (19.9%).


Discover growth companies